Bank of New York Mellon’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,681
Closed -$20.2K 4465
2023
Q1
$20.2K Hold
12,681
﹤0.01% 4305
2022
Q4
$18.5K Sell
12,681
-46
-0.4% -$67 ﹤0.01% 4365
2022
Q3
$54K Hold
12,727
﹤0.01% 4305
2022
Q2
$49K Sell
12,727
-96,488
-88% -$371K ﹤0.01% 4347
2022
Q1
$520K Sell
109,215
-798
-0.7% -$3.8K ﹤0.01% 3680
2021
Q4
$402K Buy
110,013
+2,075
+2% +$7.58K ﹤0.01% 3933
2021
Q3
$866K Buy
107,938
+9,643
+10% +$77.4K ﹤0.01% 3470
2021
Q2
$1.12M Buy
+98,295
New +$1.12M ﹤0.01% 3337
2019
Q1
Sell
-287
Closed -$4K 4254
2018
Q4
$4K Hold
287
﹤0.01% 4212
2018
Q3
$20K Hold
287
﹤0.01% 4199
2018
Q2
$21K Sell
287
-67
-19% -$4.9K ﹤0.01% 4159
2018
Q1
$33K Buy
354
+67
+23% +$6.25K ﹤0.01% 4212
2017
Q4
$37K Buy
+287
New +$37K ﹤0.01% 4226
2016
Q3
Sell
-287
Closed -$33K 4318
2016
Q2
$33K Buy
287
+6
+2% +$690 ﹤0.01% 4232
2016
Q1
$32K Sell
281
-25
-8% -$2.85K ﹤0.01% 4133
2015
Q4
$58K Buy
306
+25
+9% +$4.74K ﹤0.01% 4126
2015
Q3
$48K Hold
281
﹤0.01% 4197
2015
Q2
$177K Sell
281
-727
-72% -$458K ﹤0.01% 3913
2015
Q1
$518K Sell
1,008
-3
-0.3% -$1.54K ﹤0.01% 3589
2014
Q4
$542K Sell
1,011
-602
-37% -$323K ﹤0.01% 3586
2014
Q3
$2.42M Buy
1,613
+374
+30% +$561K ﹤0.01% 2749
2014
Q2
$1.7M Buy
1,239
+424
+52% +$580K ﹤0.01% 3002
2014
Q1
$1.13M Buy
815
+10
+1% +$13.9K ﹤0.01% 3206
2013
Q4
$801K Sell
805
-4
-0.5% -$3.98K ﹤0.01% 3399
2013
Q3
$842K Sell
809
-5,462
-87% -$5.68M ﹤0.01% 3324
2013
Q2
$6.83M Buy
+6,271
New +$6.83M ﹤0.01% 2009